COMMUNIQUÉS West-GlobeNewswire

Alder BioPharmaceuticals, Inc. Announces Exercise in Full of Underwriters’ Option to Purchase Additional 2.50% Convertible Senior Notes Due 2025
13/02/2018
BOTHELL, Wash., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, announced [...]
Medovex Corporation Presents Initial Data on the DenerveX® System During NSpine 2nd Platinum Course in Arosa, Switzerland
13/02/2018
ATLANTA, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB:MDVX) ("Medovex" or the "Company"), the developer of the DenerveX® System, a new and novel device designed for enduring relief of Facet Joint Syndrome [...]
Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women’s Initiative for Heart Recovery
13/02/2018
DANVERS, Mass., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD ), a leading provider of breakthrough heart support and recovery technologies, announced today the launch of a new indication and Women’s [...]
Daré Bioscience, Inc. to raise approximately $10.25 million
13/02/2018
SAN DIEGO, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ) today announced the pricing of its previously announced underwritten public offering of 5.0 million shares of its common stock and [...]
Scythian Biosciences Announces Closing of $28.7 Million Financing with Aphria Inc. as Lead Investor
13/02/2018
TORONTO, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt: 9SB ) (OTCQB:SCCYF) is pleased to announce that it has today closed its previously [...]
Oxford Immunotec Schedules Fourth Quarter and Full Year 2017 Earnings Release and Conference Call for February 27, 2018
13/02/2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company, today announced that it plans to release fourth [...]
Medtronic Announces Upcoming Data Presentations at the Advanced Technologies and Treatments for Diabetes 11th International Conference
13/02/2018
Medtronic Will Host an Exclusive Symposium on Thursday, February 15 VIENNA - February 13, 2018 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, today announced its schedule of notable sessions that [...]
Medecision drives the next generation of care management in 2017
13/02/2018
DALLAS, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Medecision , the leader in care management and population health solutions for risk-bearing entities, announces that 2017 was another successful year in its drive toward [...]
Benefits by Design (BBD) Inc. Partners with Telemedicine Company GOeVisit to innovate access to medical care
13/02/2018
VANCOUVER, British Columbia, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Benefits By Design (BBD), a third party administrator that connects Canadian businesses with benefits and workplace solutions, has partnered with MyCare [...]
OrthoPediatrics Corp. to Participate in BTIG Healthcare Conference
13/02/2018
WARSAW, Ind., Feb. 13, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS ), an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market, [...]
Lexington Delivers 1st Generation HeartSentry for Clinical Trials
13/02/2018
VANCOUVER, British Columbia, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is pleased to advise that [...]
Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock
13/02/2018
MENLO PARK, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB ) (the “Company”) today announced that it has priced its previously announced underwritten public offering of [...]
Catalyst Biosciences Announces Pricing of Public Offering of Common Stock
13/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]
Teladoc to Announce Fourth Quarter and Full-Year 2017 Financial Results
13/02/2018
PURCHASE, NY, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE: TDOC ), the world’s largest and most trusted provider of virtual care delivery services, announced today that it will release fourth quarter and full [...]
Microbot Medical’s CEO to Speak as an Industry Expert at the YJP CEO Healthcare Symposium
13/02/2018
HINGHAM, Mass., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT ), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today [...]
DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company
13/02/2018
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social
13/02/2018
Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]
Trading in Novo Nordisk shares by board members, executives and associated persons on 12 February 2018
13/02/2018
Bagsværd, Denmark, 13 February 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article [...]
Novan to Present Integrated Data from Phase 3 Trials with SB204 for Treatment of Acne
13/02/2018
MORRISVILLE, N.C., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ: NOVN ) today announced that data from the Company’s two Phase 3 clinical trials and long-term safety trial with SB204 [...]

Pages